Latest News and Press Releases

SOUTH SAN FRANCISCO, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address...

Q1 total revenue year-over-year growth of 22% to $132.2 millionARR year-over-year growth of 21% to $526.6 million as of March 31, 2023Cash flow provided by operations of $68.2 million for the TTM...

Arcadia and DynaEnergetics Deliver Solid Sequential Sales Growth & Margin Expansion;NobelClad’s Order Backlog Reaches 10-year High First quarter sales were a record $184.3 million, up 5%...

First Quarter 2023 Highlights Product revenue of $500.7 million, up 35% year over yearService revenue of $761.6 million, up 30% year over yearTotal revenue of $1.26 billion, up 32% year over...

Generated U.S. net product revenues of $18.4 million for SYFOVRE™ (pegcetacoplan injection) and $20.4 million for EMPAVELI® (pegcetacoplan) SYFOVRE launched in the U.S. as the first and only treatment...

COSTA MESA, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- El Pollo Loco Holdings, Inc. (Nasdaq: LOCO) today announced financial results for the 13-week period ended March 29, 2023 Highlights for the...

Board of Directors Declared Total Dividends of $0.70 Per Share for Second Quarter 2023 Base Dividend of $0.41, Supplemental Dividend of $0.19, and Special Dividend of $0.10 Per Share EVANSTON, Ill.,...

- Grew Q1 2023 Revenue 27%, System-wide Sales 17% and System-wide Comp Sales 8% vs. Q1 2022 -- Increased Clinic Count to 870, Including 130 Company-Owned or Managed Clinics, at March 31, 2023 - ...

First quarter 2023 revenue increased 27% year-over-year to $14.5 million Full-year revenue guidance updated on strength of first quarter performance. Now expected to be $52-$54 million, up from...

NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Virtu Financial, Inc. (“Virtu” or the “Company”) (NASDAQ: VIRT).   Such investors are...